Skip to main content
. 2016 Mar 1;97(Pt 3):756–766. doi: 10.1099/jgv.0.000379

Table 1. Sequences of primers used in this study.

Name Sequence (5′–3′)
VP51-P1 GGAAGCTTCGATGCTGTTTGTAGTGCTCGTCTTG
VP51-P2 CGGGGTACCCCGATCCATTTTGCGGTTCTGTTG
VP51-P3 CGGGGTACCCCGGTTCGCTGGTTCCGTTCT
VP51-P4 CCAAGCTTGGATGCTGTTTGTAGTGCTCGTCTTG
VP51-P5 GTAAAAACCTCTTTCACATTTTTCCTCTTCCATATAGAAACCGTTG
VP51-P6 CTCTTCCATATAGAAACCGTTGGAAAAATGTGAAAGAGGTT
VP51-P7 CCGCTCGAGATCCATTTTGCGGTTCTGTTG
VP51-P8 GTAATAGCCGTCCTTTGGTTTTTCGCATTTGGTTGTTCTGTC
VP51-P9 GATGACAGAACAACCAAATGCGAAAAACCAAAGGACGGCTATTAC
VP51-P10 CCATTGAAAGGGTGGGTTTCCAATTATTGGTTTGGCGTAC
VP51-P11 GTACGTACGCCAAACCAATAATTGGAAACCCACCCTTTCAATG
VP51-P12 ATGCTGTTTGTAGTGCTCGTCTTG
VP51-P13 AGTGTTCGCTGGTTCCGTTC
VP51-P14 ATCCATTTTGCGGTTCTGTTG
MCP-PF-P15 ACTCGTAAGATCGCCACGGAAGATT
MCP-PR-P16 ACGTTTCTCAAATGCATGTCTGCCAC
ICP18-PF-P17 ATCGGATCTACGTGGTTGG
ICP18-PR-P18 CCGTCGTCGGTGTCTATTC
LITAF-PF-P19 GATGCTGCCGTGTGAACTG
LITAF-PR-P20 GCACATCCTTGGTGGTGTTG
FHM-Actin-PF-P21 TCTTCCAGCCATCCTTCCTTGG
FHM-Actin-PR-P22 CTGCATACGGTCAGCAATGCC
GS-Actin-PF-P23 TACGAGCTGCCTGACGGACA
GS-Actin-PR-P24 GGCTGTGATCTCCTTCTGCA